These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18310567)

  • 1. Coordinating the approach to bluetongue.
    Brownlie J
    Vet Rec; 2008 Mar; 162(9):287. PubMed ID: 18310567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 3. [To vaccinate against bluetongue or not?].
    Backer J
    Tijdschr Diergeneeskd; 2009 Apr; 134(8):348-9. PubMed ID: 19462622
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination considered the only practical safeguard against bluetongue.
    Vet Rec; 2008 Feb; 162(7):194-5. PubMed ID: 18389575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination against bluetongue: safety and immune response in the field].
    Bruckner L; Fricker R; Hug M; Hotz R; Muntwyler J; Iten C; Griot C
    Schweiz Arch Tierheilkd; 2009 Mar; 151(3):101-8. PubMed ID: 19263379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A lot of interest in blue tongue vaccination].
    Haneveld JK
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):622-3. PubMed ID: 18767305
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination... Health by injection?].
    De symposiumcommissie van VVFC De Uithof
    Tijdschr Diergeneeskd; 2006 Nov; 131(21):795. PubMed ID: 17137226
    [No Abstract]   [Full Text] [Related]  

  • 8. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden.
    Hultén C; Frössling J; Chenais E; Sternberg Lewerin S
    Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
    Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
    Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific study of bluetongue vaccine uptake and efficacy.
    Wood J; Webb C; Oura C
    Vet Rec; 2008 Jun; 162(25):831. PubMed ID: 18567937
    [No Abstract]   [Full Text] [Related]  

  • 12. Bluetongue in cattle: a review.
    Goltz J
    Can Vet J; 1978 Apr; 19(4):95-8. PubMed ID: 207405
    [No Abstract]   [Full Text] [Related]  

  • 13. Bluetongue control in Europe--new challenges and achievements.
    Makoschey B; Maclachlan J; v Wuijckhuise L; Kirschvink N; dal Pozzo F; Petit H; Kaandorp-Huber C; v Rijn P; Sellal E; Oura C; Boinas F; Cavirani S; de Clercq K; Lucientes J; Meijjes CP; Zientara S; Meyer G; Thiry E
    Berl Munch Tierarztl Wochenschr; 2009; 122(7-8):314-24. PubMed ID: 19681404
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency and efficacy of inactivated bluetongue virus vaccines.
    Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
    Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus.
    Wark MC; Shepherd-Clark MB; Smith HV; Collins WD
    Aust Vet J; 1982 Jul; 59(1):6-10. PubMed ID: 6293439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bluetongue vaccine in Scotland.
    Bartram D
    Vet Rec; 2008 Nov; 163(21):638. PubMed ID: 19029114
    [No Abstract]   [Full Text] [Related]  

  • 18. Contamination in bluetongue virus challenge experiments.
    Eschbaumer M; Wäckerlin R; Savini G; Zientara S; Sailleau C; Bréard E; Beer M; Hoffmann B
    Vaccine; 2011 Jun; 29(26):4299-301. PubMed ID: 21557978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
    Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep.
    Ramakrishnan MA; Pandey AB; Singh KP; Singh R; Nandi S; Mehrotra ML
    Vet Res Commun; 2006 Nov; 30(8):873-80. PubMed ID: 17139537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.